Literature DB >> 14638924

Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.

Alfred K Cheung1, Nathan W Levin, Tom Greene, Lawrence Agodoa, James Bailey, Gerald Beck, William Clark, Andrew S Levey, John K Leypoldt, Daniel B Ornt, Michael V Rocco, Gerald Schulman, Steve Schwab, Brendan Teehan, Garabed Eknoyan.   

Abstract

Among the 1846 patients in the HEMO Study, chronic high-flux dialysis did not significantly affect the primary outcome of the all-cause mortality (ACM) rate or the main secondary composite outcomes, including the rates of first cardiac hospitalization or ACM, first infectious hospitalization or ACM, first 15% decrease in serum albumin levels or ACM, or all non-vascular access-related hospitalizations. The high-flux intervention, however, seemed to be associated with reduced risks of specific cardiac-related events. The relative risks (RR) for the high-flux arm, compared with the low-flux arm, were 0.80 [95% confidence interval (CI), 0.65 to 0.99] for cardiac death and 0.87 (95% CI, 0.76 to 1.00) for the composite of first cardiac hospitalization or cardiac death. Also, the effect of high-flux dialysis on ACM seemed to vary, depending on the duration of prior dialysis. This report presents secondary analyses to further explore the relationship between the flux intervention and the duration of dialysis with respect to various outcomes. The patients were stratified into a short-duration group and a long-duration group, on the basis of the mean duration of dialysis of 3.7 yr before randomization. In the subgroup that had been on dialysis for >3.7 yr, randomization to high-flux dialysis was associated with lower risks of ACM (RR, 0.68; 95% CI, 0.53 to 0.86; P = 0.001), the composite of first albumin level decrease or ACM (RR, 0.74; 95% CI, 0.60 to 0.91; P = 0.005), and cardiac deaths (RR, 0.63; 95% CI, 0.43 to 0.92; P = 0.016), compared with low-flux dialysis. No significant differences were observed in outcomes related to infection for either duration subgroup, however, and the trends for beneficial effects of high-flux dialysis on ACM rates were considerably weakened when the years of dialysis during the follow-up phase were combined with the prestudy years of dialysis in the analysis. For the subgroup of patients with <3.7 yr of dialysis before the study, assignment to high-flux dialysis had no significant effect on any of the examined clinical outcomes. These data suggest that high-flux dialysis might have a beneficial effect on cardiac outcomes. Because these results are derived from multiple statistical comparisons, however, they must be interpreted with caution. The subgroup results that demonstrate that patients with different durations of dialysis are affected differently by high-flux dialysis are interesting and require further study for confirmation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638924     DOI: 10.1097/01.asn.0000096373.13406.94

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

1.  Mortality associated with low serum sodium concentration in maintenance hemodialysis.

Authors:  Sushrut S Waikar; Gary C Curhan; Steven M Brunelli
Journal:  Am J Med       Date:  2011-01       Impact factor: 4.965

2.  Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes.

Authors:  Muriel P C Grooteman; Marinus A van den Dorpel; Michiel L Bots; E Lars Penne; Neelke C van der Weerd; Albert H A Mazairac; Claire H den Hoedt; Ingeborg van der Tweel; Renée Lévesque; Menso J Nubé; Piet M ter Wee; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

3.  Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients.

Authors:  Vanessa A Ravel; Miklos Z Molnar; Elani Streja; Jun Chul Kim; Alla Victoroff; Jennie Jing; Debbie Benner; Keith C Norris; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Nutr       Date:  2013-05-22       Impact factor: 4.798

4.  Dialysis: Some patients may benefit from using high-flux membranes.

Authors:  Victor F Seabra; Jacob J Clarenbach; Bertrand L Jaber
Journal:  Nat Rev Nephrol       Date:  2009-08       Impact factor: 28.314

Review 5.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

Review 6.  Home haemodialysis and uraemic toxin removal: does a happy marriage exist?

Authors:  Raymond Vanholder; Sunny Eloot; Nathalie Neirynck; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

Review 7.  Water quality in conventional and home haemodialysis.

Authors:  Matthew J Damasiewicz; Kevan R Polkinghorne; Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

8.  Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Authors:  Joon-Sung Park; Gheun-Ho Kim; Chong Myung Kang; Chang Hwa Lee
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 3.165

9.  Modulation of the immune response to HBV vaccination by hemodialysis membranes.

Authors:  Fatih Dede; Ayla Yıldız; Deniz Aylı; Nujen Colak; Ali Rıza Odabaş; Hadim Akoğlu; Erdal Eskioğlu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2009-07-19       Impact factor: 2.370

10.  Haemodiafiltration-optimal efficiency and safety.

Authors:  Ingrid Ledebo; Peter J Blankestijn
Journal:  NDT Plus       Date:  2009-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.